Long-term efficacy and safety of momelotinib, a JAK1 and JAK2 inhibitor, for the treatment of myelofibrosis. (Record no. 27911036)

MARC details
000 -LEADER
fixed length control field 01560 a2200469 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517192311.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201902s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1476-5551
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1038/leu.2017.330
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Pardanani, A
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20190219
245 00 - TITLE STATEMENT
Title Long-term efficacy and safety of momelotinib, a JAK1 and JAK2 inhibitor, for the treatment of myelofibrosis.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Leukemia
Date of publication, distribution, etc. 04 2018
300 ## - PHYSICAL DESCRIPTION
Extent 1035-1038 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Letter; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Benzamides
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Janus Kinase 1
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Janus Kinase 2
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Primary Myelofibrosis
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein Kinase Inhibitors
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrimidines
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thrombocytosis
General subdivision drug therapy
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gotlib, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Roberts, A W
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wadleigh, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sirhan, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kawashima, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Maltzman, J A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Shao, L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gupta, V
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tefferi, A
773 0# - HOST ITEM ENTRY
Title Leukemia
Related parts vol. 32
-- no. 4
-- p. 1035-1038
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1038/leu.2017.330">https://doi.org/10.1038/leu.2017.330</a>
Public note Available from publisher's website

No items available.